nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—CYP1A2—Carmustine—brain cancer	0.191	0.348	CbGbCtD
Riluzole—ABCG2—Carboplatin—brain cancer	0.163	0.298	CbGbCtD
Riluzole—ABCG2—Etoposide—brain cancer	0.137	0.25	CbGbCtD
Riluzole—CYP1A2—Etoposide—brain cancer	0.0565	0.103	CbGbCtD
Riluzole—SLC7A11—Basigin interactions—BSG—brain cancer	0.004	0.11	CbGpPWpGaD
Riluzole—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00287	0.0791	CbGpPWpGaD
Riluzole—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00261	0.0719	CbGpPWpGaD
Riluzole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00183	0.0504	CbGpPWpGaD
Riluzole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00166	0.0459	CbGpPWpGaD
Riluzole—CYP1A1—Xenobiotics—CYP2C9—brain cancer	0.00138	0.038	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—BSG—brain cancer	0.00133	0.0366	CbGpPWpGaD
Riluzole—CYP1A1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00133	0.0365	CbGpPWpGaD
Riluzole—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000879	0.0242	CbGpPWpGaD
Riluzole—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000845	0.0233	CbGpPWpGaD
Riluzole—ABCG2—Irinotecan Pathway—APC—brain cancer	0.000718	0.0198	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—HES5—brain cancer	0.0007	0.0193	CbGpPWpGaD
Riluzole—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000662	0.0182	CbGpPWpGaD
Riluzole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000575	0.0158	CbGpPWpGaD
Riluzole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000572	0.0158	CbGpPWpGaD
Riluzole—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000565	0.0156	CbGpPWpGaD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000545	0.015	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—MPL—brain cancer	0.000534	0.0147	CbGpPWpGaD
Riluzole—Sinusitis—Temozolomide—brain cancer	0.000533	0.00128	CcSEcCtD
Riluzole—Somnolence—Procarbazine—brain cancer	0.000532	0.00128	CcSEcCtD
Riluzole—Haemoglobin—Carmustine—brain cancer	0.00053	0.00127	CcSEcCtD
Riluzole—Haemorrhage—Carmustine—brain cancer	0.000527	0.00127	CcSEcCtD
Riluzole—Ill-defined disorder—Hydroxyurea—brain cancer	0.000527	0.00127	CcSEcCtD
Riluzole—Anaemia—Hydroxyurea—brain cancer	0.000525	0.00126	CcSEcCtD
Riluzole—Hallucination—Carmustine—brain cancer	0.000525	0.00126	CcSEcCtD
Riluzole—Hypoaesthesia—Carmustine—brain cancer	0.000525	0.00126	CcSEcCtD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—PDGFRA—brain cancer	0.000522	0.0144	CbGpPWpGaD
Riluzole—Decreased appetite—Procarbazine—brain cancer	0.000521	0.00125	CcSEcCtD
Riluzole—Alanine aminotransferase increased—Etoposide—brain cancer	0.00052	0.00125	CcSEcCtD
Riluzole—Oedema peripheral—Carmustine—brain cancer	0.00052	0.00125	CcSEcCtD
Riluzole—Connective tissue disorder—Carmustine—brain cancer	0.000518	0.00125	CcSEcCtD
Riluzole—Fatigue—Procarbazine—brain cancer	0.000516	0.00124	CcSEcCtD
Riluzole—Haemoglobin—Temozolomide—brain cancer	0.000512	0.00123	CcSEcCtD
Riluzole—Malaise—Hydroxyurea—brain cancer	0.000512	0.00123	CcSEcCtD
Riluzole—Pain—Procarbazine—brain cancer	0.000512	0.00123	CcSEcCtD
Riluzole—Constipation—Procarbazine—brain cancer	0.000512	0.00123	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—S100A10—brain cancer	0.000512	0.0141	CbGpPWpGaD
Riluzole—Hepatitis—Temozolomide—brain cancer	0.00051	0.00122	CcSEcCtD
Riluzole—Haemorrhage—Temozolomide—brain cancer	0.00051	0.00122	CcSEcCtD
Riluzole—Dysphagia—Etoposide—brain cancer	0.000509	0.00122	CcSEcCtD
Riluzole—Leukopenia—Hydroxyurea—brain cancer	0.000508	0.00122	CcSEcCtD
Riluzole—Hallucination—Temozolomide—brain cancer	0.000507	0.00122	CcSEcCtD
Riluzole—Hypoaesthesia—Temozolomide—brain cancer	0.000507	0.00122	CcSEcCtD
Riluzole—Pharyngitis—Temozolomide—brain cancer	0.000506	0.00122	CcSEcCtD
Riluzole—Urinary tract disorder—Temozolomide—brain cancer	0.000503	0.00121	CcSEcCtD
Riluzole—Oedema peripheral—Temozolomide—brain cancer	0.000502	0.00121	CcSEcCtD
Riluzole—Connective tissue disorder—Temozolomide—brain cancer	0.000501	0.0012	CcSEcCtD
Riluzole—Urethral disorder—Temozolomide—brain cancer	0.0005	0.0012	CcSEcCtD
Riluzole—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000496	0.0137	CbGpPWpGaD
Riluzole—Feeling abnormal—Procarbazine—brain cancer	0.000493	0.00119	CcSEcCtD
Riluzole—Eye disorder—Carmustine—brain cancer	0.000493	0.00118	CcSEcCtD
Riluzole—Convulsion—Hydroxyurea—brain cancer	0.000492	0.00118	CcSEcCtD
Riluzole—Gastrointestinal pain—Procarbazine—brain cancer	0.00049	0.00118	CcSEcCtD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000485	0.0134	CbGpPWpGaD
Riluzole—Pancytopenia—Etoposide—brain cancer	0.000484	0.00116	CcSEcCtD
Riluzole—Erythema multiforme—Temozolomide—brain cancer	0.000482	0.00116	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00048	0.00115	CcSEcCtD
Riluzole—Discomfort—Hydroxyurea—brain cancer	0.000478	0.00115	CcSEcCtD
Riluzole—Neutropenia—Etoposide—brain cancer	0.000476	0.00114	CcSEcCtD
Riluzole—Eye disorder—Temozolomide—brain cancer	0.000476	0.00114	CcSEcCtD
Riluzole—Urticaria—Procarbazine—brain cancer	0.000476	0.00114	CcSEcCtD
Riluzole—Abdominal pain—Procarbazine—brain cancer	0.000473	0.00114	CcSEcCtD
Riluzole—Body temperature increased—Procarbazine—brain cancer	0.000473	0.00114	CcSEcCtD
Riluzole—Cardiac disorder—Temozolomide—brain cancer	0.000473	0.00114	CcSEcCtD
Riluzole—Arrhythmia—Carmustine—brain cancer	0.000471	0.00113	CcSEcCtD
Riluzole—Alopecia—Carmustine—brain cancer	0.000466	0.00112	CcSEcCtD
Riluzole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000464	0.0128	CbGpPWpGaD
Riluzole—Oedema—Hydroxyurea—brain cancer	0.000463	0.00111	CcSEcCtD
Riluzole—Angiopathy—Temozolomide—brain cancer	0.000462	0.00111	CcSEcCtD
Riluzole—Mental disorder—Carmustine—brain cancer	0.000462	0.00111	CcSEcCtD
Riluzole—Infection—Hydroxyurea—brain cancer	0.00046	0.00111	CcSEcCtD
Riluzole—Immune system disorder—Temozolomide—brain cancer	0.00046	0.00111	CcSEcCtD
Riluzole—Mediastinal disorder—Temozolomide—brain cancer	0.000459	0.0011	CcSEcCtD
Riluzole—Malnutrition—Carmustine—brain cancer	0.000459	0.0011	CcSEcCtD
Riluzole—Chills—Temozolomide—brain cancer	0.000457	0.0011	CcSEcCtD
Riluzole—Pneumonia—Etoposide—brain cancer	0.000457	0.0011	CcSEcCtD
Riluzole—Nervous system disorder—Hydroxyurea—brain cancer	0.000455	0.00109	CcSEcCtD
Riluzole—Infestation NOS—Etoposide—brain cancer	0.000454	0.00109	CcSEcCtD
Riluzole—Infestation—Etoposide—brain cancer	0.000454	0.00109	CcSEcCtD
Riluzole—Thrombocytopenia—Hydroxyurea—brain cancer	0.000454	0.00109	CcSEcCtD
Riluzole—Alopecia—Temozolomide—brain cancer	0.00045	0.00108	CcSEcCtD
Riluzole—Skin disorder—Hydroxyurea—brain cancer	0.00045	0.00108	CcSEcCtD
Riluzole—Acute coronary syndrome—Etoposide—brain cancer	0.000448	0.00108	CcSEcCtD
Riluzole—Mental disorder—Temozolomide—brain cancer	0.000446	0.00107	CcSEcCtD
Riluzole—Neuropathy peripheral—Etoposide—brain cancer	0.000445	0.00107	CcSEcCtD
Riluzole—Myocardial infarction—Etoposide—brain cancer	0.000445	0.00107	CcSEcCtD
Riluzole—Back pain—Carmustine—brain cancer	0.000444	0.00107	CcSEcCtD
Riluzole—Malnutrition—Temozolomide—brain cancer	0.000444	0.00107	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—S100A10—brain cancer	0.000443	0.0122	CbGpPWpGaD
Riluzole—Jaundice—Etoposide—brain cancer	0.000443	0.00106	CcSEcCtD
Riluzole—Stomatitis—Etoposide—brain cancer	0.000443	0.00106	CcSEcCtD
Riluzole—Anorexia—Hydroxyurea—brain cancer	0.000442	0.00106	CcSEcCtD
Riluzole—Hypersensitivity—Procarbazine—brain cancer	0.000441	0.00106	CcSEcCtD
Riluzole—Dysgeusia—Temozolomide—brain cancer	0.000434	0.00104	CcSEcCtD
Riluzole—Tremor—Carmustine—brain cancer	0.00043	0.00103	CcSEcCtD
Riluzole—Asthenia—Procarbazine—brain cancer	0.00043	0.00103	CcSEcCtD
Riluzole—Hepatobiliary disease—Etoposide—brain cancer	0.00043	0.00103	CcSEcCtD
Riluzole—Back pain—Temozolomide—brain cancer	0.000429	0.00103	CcSEcCtD
Riluzole—Anaemia—Carmustine—brain cancer	0.000424	0.00102	CcSEcCtD
Riluzole—Agranulocytosis—Etoposide—brain cancer	0.000424	0.00102	CcSEcCtD
Riluzole—Pruritus—Procarbazine—brain cancer	0.000424	0.00102	CcSEcCtD
Riluzole—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000422	0.0116	CbGpPWpGaD
Riluzole—Agitation—Carmustine—brain cancer	0.000422	0.00101	CcSEcCtD
Riluzole—Tremor—Temozolomide—brain cancer	0.000416	0.000999	CcSEcCtD
Riluzole—Dyspnoea—Hydroxyurea—brain cancer	0.000413	0.000993	CcSEcCtD
Riluzole—Somnolence—Hydroxyurea—brain cancer	0.000412	0.00099	CcSEcCtD
Riluzole—Ill-defined disorder—Temozolomide—brain cancer	0.000412	0.000989	CcSEcCtD
Riluzole—Leukopenia—Carmustine—brain cancer	0.000411	0.000987	CcSEcCtD
Riluzole—Anaemia—Temozolomide—brain cancer	0.00041	0.000985	CcSEcCtD
Riluzole—Diarrhoea—Procarbazine—brain cancer	0.00041	0.000985	CcSEcCtD
Riluzole—Dyspepsia—Hydroxyurea—brain cancer	0.000408	0.00098	CcSEcCtD
Riluzole—Agitation—Temozolomide—brain cancer	0.000408	0.00098	CcSEcCtD
Riluzole—Hypoaesthesia—Etoposide—brain cancer	0.000406	0.000975	CcSEcCtD
Riluzole—Angioedema—Temozolomide—brain cancer	0.000405	0.000974	CcSEcCtD
Riluzole—Decreased appetite—Hydroxyurea—brain cancer	0.000403	0.000968	CcSEcCtD
Riluzole—Urinary tract disorder—Etoposide—brain cancer	0.000403	0.000968	CcSEcCtD
Riluzole—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.0004	0.000961	CcSEcCtD
Riluzole—Malaise—Temozolomide—brain cancer	0.0004	0.000961	CcSEcCtD
Riluzole—Urethral disorder—Etoposide—brain cancer	0.0004	0.000961	CcSEcCtD
Riluzole—Fatigue—Hydroxyurea—brain cancer	0.0004	0.00096	CcSEcCtD
Riluzole—Vertigo—Temozolomide—brain cancer	0.000399	0.000958	CcSEcCtD
Riluzole—Convulsion—Carmustine—brain cancer	0.000398	0.000956	CcSEcCtD
Riluzole—Leukopenia—Temozolomide—brain cancer	0.000397	0.000954	CcSEcCtD
Riluzole—Hypertension—Carmustine—brain cancer	0.000396	0.000952	CcSEcCtD
Riluzole—Constipation—Hydroxyurea—brain cancer	0.000396	0.000952	CcSEcCtD
Riluzole—Pain—Hydroxyurea—brain cancer	0.000396	0.000952	CcSEcCtD
Riluzole—Dizziness—Procarbazine—brain cancer	0.000396	0.000952	CcSEcCtD
Riluzole—Palpitations—Temozolomide—brain cancer	0.000392	0.000942	CcSEcCtD
Riluzole—Chest pain—Carmustine—brain cancer	0.000391	0.000939	CcSEcCtD
Riluzole—Myalgia—Carmustine—brain cancer	0.000391	0.000939	CcSEcCtD
Riluzole—Anxiety—Carmustine—brain cancer	0.000389	0.000936	CcSEcCtD
Riluzole—Cough—Temozolomide—brain cancer	0.000387	0.00093	CcSEcCtD
Riluzole—Erythema multiforme—Etoposide—brain cancer	0.000386	0.000926	CcSEcCtD
Riluzole—Convulsion—Temozolomide—brain cancer	0.000384	0.000924	CcSEcCtD
Riluzole—Hypertension—Temozolomide—brain cancer	0.000383	0.00092	CcSEcCtD
Riluzole—Feeling abnormal—Hydroxyurea—brain cancer	0.000382	0.000918	CcSEcCtD
Riluzole—Eye disorder—Etoposide—brain cancer	0.000381	0.000916	CcSEcCtD
Riluzole—Vomiting—Procarbazine—brain cancer	0.000381	0.000915	CcSEcCtD
Riluzole—Cardiac disorder—Etoposide—brain cancer	0.000378	0.000909	CcSEcCtD
Riluzole—Confusional state—Carmustine—brain cancer	0.000378	0.000908	CcSEcCtD
Riluzole—Arthralgia—Temozolomide—brain cancer	0.000378	0.000908	CcSEcCtD
Riluzole—Myalgia—Temozolomide—brain cancer	0.000378	0.000908	CcSEcCtD
Riluzole—Rash—Procarbazine—brain cancer	0.000378	0.000907	CcSEcCtD
Riluzole—Dermatitis—Procarbazine—brain cancer	0.000377	0.000906	CcSEcCtD
Riluzole—Anxiety—Temozolomide—brain cancer	0.000376	0.000904	CcSEcCtD
Riluzole—Headache—Procarbazine—brain cancer	0.000375	0.000901	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000375	0.000901	CcSEcCtD
Riluzole—Oedema—Carmustine—brain cancer	0.000375	0.0009	CcSEcCtD
Riluzole—Discomfort—Temozolomide—brain cancer	0.000373	0.000897	CcSEcCtD
Riluzole—Infection—Carmustine—brain cancer	0.000372	0.000894	CcSEcCtD
Riluzole—Angiopathy—Etoposide—brain cancer	0.00037	0.000889	CcSEcCtD
Riluzole—Dry mouth—Temozolomide—brain cancer	0.000369	0.000888	CcSEcCtD
Riluzole—Immune system disorder—Etoposide—brain cancer	0.000368	0.000885	CcSEcCtD
Riluzole—Mediastinal disorder—Etoposide—brain cancer	0.000368	0.000883	CcSEcCtD
Riluzole—Thrombocytopenia—Carmustine—brain cancer	0.000367	0.000881	CcSEcCtD
Riluzole—Body temperature increased—Hydroxyurea—brain cancer	0.000366	0.00088	CcSEcCtD
Riluzole—Chills—Etoposide—brain cancer	0.000366	0.000879	CcSEcCtD
Riluzole—Tachycardia—Carmustine—brain cancer	0.000366	0.000879	CcSEcCtD
Riluzole—Confusional state—Temozolomide—brain cancer	0.000365	0.000877	CcSEcCtD
Riluzole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000365	0.0101	CbGpPWpGaD
Riluzole—Anaphylactic shock—Temozolomide—brain cancer	0.000362	0.00087	CcSEcCtD
Riluzole—Oedema—Temozolomide—brain cancer	0.000362	0.00087	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—BSG—brain cancer	0.00036	0.00994	CbGpPWpGaD
Riluzole—Alopecia—Etoposide—brain cancer	0.00036	0.000866	CcSEcCtD
Riluzole—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00036	0.00992	CbGpPWpGaD
Riluzole—Infection—Temozolomide—brain cancer	0.00036	0.000864	CcSEcCtD
Riluzole—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000357	0.00984	CbGpPWpGaD
Riluzole—Anorexia—Carmustine—brain cancer	0.000357	0.000858	CcSEcCtD
Riluzole—Nausea—Procarbazine—brain cancer	0.000356	0.000855	CcSEcCtD
Riluzole—Nervous system disorder—Temozolomide—brain cancer	0.000355	0.000853	CcSEcCtD
Riluzole—Thrombocytopenia—Temozolomide—brain cancer	0.000355	0.000852	CcSEcCtD
Riluzole—Skin disorder—Temozolomide—brain cancer	0.000352	0.000845	CcSEcCtD
Riluzole—Hypotension—Carmustine—brain cancer	0.00035	0.000841	CcSEcCtD
Riluzole—Hyperhidrosis—Temozolomide—brain cancer	0.00035	0.000841	CcSEcCtD
Riluzole—Dysgeusia—Etoposide—brain cancer	0.000348	0.000835	CcSEcCtD
Riluzole—Anorexia—Temozolomide—brain cancer	0.000345	0.000829	CcSEcCtD
Riluzole—Back pain—Etoposide—brain cancer	0.000343	0.000825	CcSEcCtD
Riluzole—Hypersensitivity—Hydroxyurea—brain cancer	0.000341	0.00082	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Carmustine—brain cancer	0.000341	0.00082	CcSEcCtD
Riluzole—Muscle spasms—Etoposide—brain cancer	0.000341	0.00082	CcSEcCtD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.00034	0.00937	CbGpPWpGaD
Riluzole—Insomnia—Carmustine—brain cancer	0.000339	0.000814	CcSEcCtD
Riluzole—Paraesthesia—Carmustine—brain cancer	0.000336	0.000808	CcSEcCtD
Riluzole—Dyspnoea—Carmustine—brain cancer	0.000334	0.000803	CcSEcCtD
Riluzole—Somnolence—Carmustine—brain cancer	0.000333	0.0008	CcSEcCtD
Riluzole—Asthenia—Hydroxyurea—brain cancer	0.000333	0.000799	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00033	0.000793	CcSEcCtD
Riluzole—Ill-defined disorder—Etoposide—brain cancer	0.000329	0.000791	CcSEcCtD
Riluzole—Anaemia—Etoposide—brain cancer	0.000328	0.000788	CcSEcCtD
Riluzole—Insomnia—Temozolomide—brain cancer	0.000327	0.000787	CcSEcCtD
Riluzole—Decreased appetite—Carmustine—brain cancer	0.000326	0.000783	CcSEcCtD
Riluzole—Paraesthesia—Temozolomide—brain cancer	0.000325	0.000781	CcSEcCtD
Riluzole—Gastrointestinal disorder—Carmustine—brain cancer	0.000323	0.000777	CcSEcCtD
Riluzole—Dyspnoea—Temozolomide—brain cancer	0.000323	0.000776	CcSEcCtD
Riluzole—Somnolence—Temozolomide—brain cancer	0.000322	0.000773	CcSEcCtD
Riluzole—Constipation—Carmustine—brain cancer	0.00032	0.00077	CcSEcCtD
Riluzole—Pain—Carmustine—brain cancer	0.00032	0.00077	CcSEcCtD
Riluzole—Malaise—Etoposide—brain cancer	0.00032	0.000769	CcSEcCtD
Riluzole—Vertigo—Etoposide—brain cancer	0.000319	0.000766	CcSEcCtD
Riluzole—Dyspepsia—Temozolomide—brain cancer	0.000319	0.000766	CcSEcCtD
Riluzole—Leukopenia—Etoposide—brain cancer	0.000318	0.000764	CcSEcCtD
Riluzole—Diarrhoea—Hydroxyurea—brain cancer	0.000317	0.000762	CcSEcCtD
Riluzole—Decreased appetite—Temozolomide—brain cancer	0.000315	0.000756	CcSEcCtD
Riluzole—Gastrointestinal disorder—Temozolomide—brain cancer	0.000313	0.000751	CcSEcCtD
Riluzole—Fatigue—Temozolomide—brain cancer	0.000312	0.00075	CcSEcCtD
Riluzole—Loss of consciousness—Etoposide—brain cancer	0.000312	0.00075	CcSEcCtD
Riluzole—Cough—Etoposide—brain cancer	0.00031	0.000744	CcSEcCtD
Riluzole—Pain—Temozolomide—brain cancer	0.00031	0.000744	CcSEcCtD
Riluzole—Constipation—Temozolomide—brain cancer	0.00031	0.000744	CcSEcCtD
Riluzole—Feeling abnormal—Carmustine—brain cancer	0.000309	0.000742	CcSEcCtD
Riluzole—Convulsion—Etoposide—brain cancer	0.000308	0.000739	CcSEcCtD
Riluzole—Hypertension—Etoposide—brain cancer	0.000306	0.000736	CcSEcCtD
Riluzole—Dizziness—Hydroxyurea—brain cancer	0.000306	0.000736	CcSEcCtD
Riluzole—Gastrointestinal pain—Carmustine—brain cancer	0.000306	0.000736	CcSEcCtD
Riluzole—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000305	0.00842	CbGpPWpGaD
Riluzole—Chest pain—Etoposide—brain cancer	0.000302	0.000726	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.0003	0.000721	CcSEcCtD
Riluzole—Discomfort—Etoposide—brain cancer	0.000299	0.000717	CcSEcCtD
Riluzole—Feeling abnormal—Temozolomide—brain cancer	0.000298	0.000717	CcSEcCtD
Riluzole—SCN5A—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000298	0.00821	CbGpPWpGaD
Riluzole—Body temperature increased—Carmustine—brain cancer	0.000296	0.000712	CcSEcCtD
Riluzole—Abdominal pain—Carmustine—brain cancer	0.000296	0.000712	CcSEcCtD
Riluzole—Gastrointestinal pain—Temozolomide—brain cancer	0.000296	0.000711	CcSEcCtD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000296	0.00815	CbGpPWpGaD
Riluzole—Vomiting—Hydroxyurea—brain cancer	0.000295	0.000708	CcSEcCtD
Riluzole—Rash—Hydroxyurea—brain cancer	0.000292	0.000702	CcSEcCtD
Riluzole—Confusional state—Etoposide—brain cancer	0.000292	0.000702	CcSEcCtD
Riluzole—Dermatitis—Hydroxyurea—brain cancer	0.000292	0.000701	CcSEcCtD
Riluzole—Headache—Hydroxyurea—brain cancer	0.00029	0.000698	CcSEcCtD
Riluzole—Anaphylactic shock—Etoposide—brain cancer	0.00029	0.000696	CcSEcCtD
Riluzole—Infection—Etoposide—brain cancer	0.000288	0.000692	CcSEcCtD
Riluzole—Urticaria—Temozolomide—brain cancer	0.000288	0.000691	CcSEcCtD
Riluzole—Abdominal pain—Temozolomide—brain cancer	0.000286	0.000688	CcSEcCtD
Riluzole—Body temperature increased—Temozolomide—brain cancer	0.000286	0.000688	CcSEcCtD
Riluzole—Thrombocytopenia—Etoposide—brain cancer	0.000284	0.000682	CcSEcCtD
Riluzole—Tachycardia—Etoposide—brain cancer	0.000283	0.000679	CcSEcCtD
Riluzole—Skin disorder—Etoposide—brain cancer	0.000281	0.000676	CcSEcCtD
Riluzole—Hyperhidrosis—Etoposide—brain cancer	0.00028	0.000673	CcSEcCtD
Riluzole—Anorexia—Etoposide—brain cancer	0.000276	0.000664	CcSEcCtD
Riluzole—Hypersensitivity—Carmustine—brain cancer	0.000276	0.000663	CcSEcCtD
Riluzole—Nausea—Hydroxyurea—brain cancer	0.000275	0.000661	CcSEcCtD
Riluzole—Hypotension—Etoposide—brain cancer	0.000271	0.00065	CcSEcCtD
Riluzole—Asthenia—Carmustine—brain cancer	0.000269	0.000646	CcSEcCtD
Riluzole—Hypersensitivity—Temozolomide—brain cancer	0.000267	0.000641	CcSEcCtD
Riluzole—Paraesthesia—Etoposide—brain cancer	0.00026	0.000625	CcSEcCtD
Riluzole—Asthenia—Temozolomide—brain cancer	0.00026	0.000624	CcSEcCtD
Riluzole—Dyspnoea—Etoposide—brain cancer	0.000258	0.000621	CcSEcCtD
Riluzole—Somnolence—Etoposide—brain cancer	0.000258	0.000619	CcSEcCtD
Riluzole—Diarrhoea—Carmustine—brain cancer	0.000256	0.000616	CcSEcCtD
Riluzole—Pruritus—Temozolomide—brain cancer	0.000256	0.000615	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000254	0.00701	CbGpPWpGaD
Riluzole—Decreased appetite—Etoposide—brain cancer	0.000252	0.000605	CcSEcCtD
Riluzole—Gastrointestinal disorder—Etoposide—brain cancer	0.00025	0.000601	CcSEcCtD
Riluzole—Fatigue—Etoposide—brain cancer	0.00025	0.0006	CcSEcCtD
Riluzole—Dizziness—Carmustine—brain cancer	0.000248	0.000595	CcSEcCtD
Riluzole—Constipation—Etoposide—brain cancer	0.000248	0.000595	CcSEcCtD
Riluzole—Pain—Etoposide—brain cancer	0.000248	0.000595	CcSEcCtD
Riluzole—Diarrhoea—Temozolomide—brain cancer	0.000248	0.000595	CcSEcCtD
Riluzole—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000246	0.00679	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000243	0.0067	CbGpPWpGaD
Riluzole—Dizziness—Temozolomide—brain cancer	0.000239	0.000575	CcSEcCtD
Riluzole—Feeling abnormal—Etoposide—brain cancer	0.000239	0.000574	CcSEcCtD
Riluzole—Vomiting—Carmustine—brain cancer	0.000238	0.000572	CcSEcCtD
Riluzole—Gastrointestinal pain—Etoposide—brain cancer	0.000237	0.000569	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—TRPC6—brain cancer	0.000236	0.00651	CbGpPWpGaD
Riluzole—Rash—Carmustine—brain cancer	0.000236	0.000568	CcSEcCtD
Riluzole—Dermatitis—Carmustine—brain cancer	0.000236	0.000567	CcSEcCtD
Riluzole—Headache—Carmustine—brain cancer	0.000235	0.000564	CcSEcCtD
Riluzole—SCN5A—SIDS Susceptibility Pathways—HES1—brain cancer	0.000231	0.00637	CbGpPWpGaD
Riluzole—Vomiting—Temozolomide—brain cancer	0.00023	0.000553	CcSEcCtD
Riluzole—Urticaria—Etoposide—brain cancer	0.00023	0.000553	CcSEcCtD
Riluzole—Body temperature increased—Etoposide—brain cancer	0.000229	0.00055	CcSEcCtD
Riluzole—Abdominal pain—Etoposide—brain cancer	0.000229	0.00055	CcSEcCtD
Riluzole—Rash—Temozolomide—brain cancer	0.000228	0.000549	CcSEcCtD
Riluzole—Dermatitis—Temozolomide—brain cancer	0.000228	0.000548	CcSEcCtD
Riluzole—Headache—Temozolomide—brain cancer	0.000227	0.000545	CcSEcCtD
Riluzole—Nausea—Carmustine—brain cancer	0.000223	0.000535	CcSEcCtD
Riluzole—Nausea—Temozolomide—brain cancer	0.000215	0.000517	CcSEcCtD
Riluzole—Hypersensitivity—Etoposide—brain cancer	0.000213	0.000513	CcSEcCtD
Riluzole—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	0.000211	0.00582	CbGpPWpGaD
Riluzole—Asthenia—Etoposide—brain cancer	0.000208	0.000499	CcSEcCtD
Riluzole—Pruritus—Etoposide—brain cancer	0.000205	0.000493	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000205	0.00564	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—TRPC6—brain cancer	0.0002	0.00551	CbGpPWpGaD
Riluzole—Diarrhoea—Etoposide—brain cancer	0.000198	0.000476	CcSEcCtD
Riluzole—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000195	0.00537	CbGpPWpGaD
Riluzole—Dizziness—Etoposide—brain cancer	0.000192	0.00046	CcSEcCtD
Riluzole—Vomiting—Etoposide—brain cancer	0.000184	0.000443	CcSEcCtD
Riluzole—Rash—Etoposide—brain cancer	0.000183	0.000439	CcSEcCtD
Riluzole—Dermatitis—Etoposide—brain cancer	0.000183	0.000439	CcSEcCtD
Riluzole—Headache—Etoposide—brain cancer	0.000182	0.000436	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—VAV1—brain cancer	0.000177	0.00488	CbGpPWpGaD
Riluzole—Nausea—Etoposide—brain cancer	0.000172	0.000413	CcSEcCtD
Riluzole—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	0.000163	0.0045	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000162	0.00447	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	0.00016	0.00442	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000157	0.00433	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000155	0.00427	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000147	0.00404	CbGpPWpGaD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000145	0.004	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TRPC6—brain cancer	0.000143	0.00393	CbGpPWpGaD
Riluzole—SCN5A—L1CAM interactions—EGFR—brain cancer	0.000136	0.00373	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000132	0.00364	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000124	0.00342	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000116	0.0032	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—PIK3CG—brain cancer	0.000112	0.0031	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000112	0.00309	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000103	0.00285	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000102	0.00281	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000101	0.00278	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000101	0.00278	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.46e-05	0.00261	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	9.35e-05	0.00258	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—HES1—brain cancer	9.2e-05	0.00253	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	8.42e-05	0.00232	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—IL2—brain cancer	7.91e-05	0.00218	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	7.41e-05	0.00204	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—ERBB2—brain cancer	7.39e-05	0.00204	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—CDK4—brain cancer	7.21e-05	0.00199	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	7.16e-05	0.00197	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.92e-05	0.00191	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—VEGFA—brain cancer	6.72e-05	0.00185	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	6.58e-05	0.00181	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	6.44e-05	0.00177	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	6.44e-05	0.00177	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP2C9—brain cancer	6.23e-05	0.00172	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.03e-05	0.00166	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—VEGFA—brain cancer	5.69e-05	0.00157	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—RELA—brain cancer	5.31e-05	0.00146	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—BSG—brain cancer	5.29e-05	0.00146	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—ERBB2—brain cancer	5.27e-05	0.00145	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—EGFR—brain cancer	5.12e-05	0.00141	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TP53—brain cancer	5.08e-05	0.0014	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—CTNNB1—brain cancer	4.61e-05	0.00127	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—IDH1—brain cancer	4.55e-05	0.00125	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.41e-05	0.00122	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP2C9—brain cancer	4.21e-05	0.00116	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—VEGFA—brain cancer	4.06e-05	0.00112	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—STAT3—brain cancer	4.02e-05	0.00111	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—EGFR—brain cancer	3.65e-05	0.00101	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ENO2—brain cancer	3.6e-05	0.000992	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—BSG—brain cancer	3.58e-05	0.000988	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—IDH1—brain cancer	3.08e-05	0.000849	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP2C9—brain cancer	2.69e-05	0.000741	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.51e-05	0.000692	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ENO2—brain cancer	2.44e-05	0.000671	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—BSG—brain cancer	2.28e-05	0.00063	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—IDH1—brain cancer	1.96e-05	0.000542	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CG—brain cancer	1.65e-05	0.000455	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.6e-05	0.000441	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ENO2—brain cancer	1.55e-05	0.000428	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CG—brain cancer	1.12e-05	0.000308	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CG—brain cancer	7.12e-06	0.000196	CbGpPWpGaD
